European Archives - Page 843 of 984 - European Medical Journal

Continue
19 Jul 2016

The Role of IL-6 in Autoimmune Disease

Rheumatoid arthritis, or RA, is an incompletely understood disorder. The complex pathophysiology of RA is regulated in part by a network of different…
EMJ
18 Jul 2016

Hip Surgery May Not Be Best Choice

EVIDENCE from a study carried out in the USA shows that arthroscopic hip surgery might not always be a suitable option for people with osteoarthritis…
EMJ
18 Jul 2016

Adalimumab Drug Suppresses Inflammation in Rheumatoid Arthritis Patients

DISCOVERY of a new function in a widely used anti-inflammatory drug could offer new insight into the divergent efficacies of different medications which…
10 Mins
15 Jul 2016

Review of the EuroPCR Congress 2016

Paris, France, played host to EuroPCR again this year; the city has a rich medical history from Paré to Pasteur and the innovations seen at this year’s…
July 2016

EMJ Interventional Cardiology 4 [Suppl 13] 2016

Coronary artery disease (CAD) is the leading cause of mortality in patients ≥60 years old worldwide, and may result in stable angina, acute coronary…
Interventional Cardiology
July 2016

EMJ Interventional Cardiology 4.1 2016

Welcome to the 2016 edition of EMJ Interventional Cardiology, an assortment of the latest news, research, and opinions from across the world from…
15 Jul 2016

How Bioresorbable Vascular Can Be Beneficial for Patients in the Long-Term

Coronary artery disease (CAD) is the leading cause of mortality in patients ≥60 years old worldwide, and may result in stable angina, acute coronary…
14 Jul 2016

Zika Experts: Varied Neurological Complications, Virus Still Detectable After Recovery

London, 14 July, 2016 – The International Congress on Neuromuscular Diseases (ICND) just drew to an end in Toronto. Among the many questions addressed…
13 Jul 2016

U.S. FDA Grants Priority Review to Janssen’s New Drug Application for Chewable Mebendazole Tablets Intended to Treat Soil-Transmitted Helminthiasis

Janssen Pharmaceuticals, Inc. announced that the U.S. FDA has granted Priority Review designation for the New Drug Application for a 500mg chewable tablet formulation of mebendazole
12 Jul 2016

Introducing EMJ Neurology 4.1

Welcome to EMJ Neurology 4.1, an edition filled with informative and engaging content which spotlights the latest research and developments in the field…